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Abstract  
Equine dysautonomia (ED, syn Equine Grass Sickness) is a neurological disease of unknown 
etiology which primarily affects grazing horses. The clinical signs reflect degeneration of specific 
neuronal populations; predominantly within the autonomic and enteric nervous systems, with 
disease severity and prognosis determined by the extent of neuronal loss. This review is primarily 
focused on the major clinical decision making processes in relation to ED; namely (a) clinical 
diagnosis, (b) selection of appropriate ancillary diagnostic tests, (c) obtaining diagnostic 
confirmation, (d) selection of treatment candidates, and (e) identifying appropriate criteria for 
euthanasia. 
  
Key Points  
 Despite the adopted nomenclature, Equine Dysautonomia (ED; syn Equine Grass 
Sickness) is a multi-system neuropathy. Although the clinical phenotype is largely 
reflective of autonomic (including enteric) nervous system dysfunction, neuronal 
degeneration occurs at other non-autonomic neuroanatomic locations [1]. 
 ED primarily affects grazing equids and a number of other disease-associated risk factors 
have been identified. 
 The etiology remains undetermined; although the currently favored etiological hypotheses 
include Clostridium botulinum toxicoinfection and mycotoxicosis [2-4]. 
 Disease phenotype is largely determined by neuronal degeneration in the autonomic and 
enteric nervous systems and prognosis is largely determined by the extent of neuronal 
degeneration in the enteric nervous system [3]. 
 Although disease phenotype is sub-classified as acute (severe), sub-acute (moderate) and 
chronic (mild), these represent different categories within a continuum of disease 
severities [5].  
 Phenotypic sub-classification is clinically justified as it offers valuable prognostic 
information; acute and sub-acute cases are invariably fatal while approximately half of 
chronic cases survive with appropriate nursing care [6]. 
 The ante-mortem diagnostic approach relies on consideration of disease-associated risk 
factors, the clinical presentation of the case, exclusion of other differential diagnoses, the 
adoption of appropriate ancillary diagnostic techniques and, on occasion, 
histopathological confirmation of enteric neuronal loss [7]. 
  The post-mortem diagnostic approach relies on histological confirmation of neuronal 
degeneration/loss within the enteric plexuses and autonomic ganglia [8]. 
 Following clinical suspicion or diagnostic confirmation of ED, short- and long-term risk 
avoidance strategies should be considered to minimize disease probability in other 
grazing equids on the same premises [5] 
 
Introduction 
Equine Dysautonomia (ED, syn Equine Grass Sickness) is a polyneuropathy affecting both the 
central and peripheral nervous systems of, almost exclusively, grazing horses. Following the 
original report of ED in 1907 [9], it has subsequently been recognized throughout most of 
Northern Europe [10-19]. Suspected cases have also been reported in the Falkland Islands [20] 
and Australia [21]. Although North America has largely been considered free of the disease, ED 
was recently described in a mule in the USA [22]. A clinically and pathologically identical 
disease, Mal Seco, is well recognized in South America [23-26]. 
Despite the reported widespread neuroanatomical distribution of degenerative neuronal lesions in 
ED, the autonomic (ANS) and enteric nervous systems (ENS) remain the most consistently and 
severely affected regions [1]. The spectrum of clinical signs which define ED largely, but not 
exclusively, reflect involvement of the ANS and ENS and the severity of disease and gross 
pathological findings can largely be attributed to the extent of enteric neuronal loss (see physical 
examination findings and pathological findings).   
Despite extensive research efforts over the past century, the etiology of ED remains elusive. 
Current research efforts are primarily focused on the potential role of either Clostridium 
botulinum neurotoxins (via toxicoinfection) [27-29] or ingested pasture-derived mycotoxins 
[3;4]. The Clostridium botulinum hypothesis was extensively investigated during the 1920s [2] 
and, and has recently received renewed interest. Table 1 summarizes the factors which either 
support or refute the involvement of C. botulinum in ED. In addition to the key association with 
grazing, the hypothesized role of pasture-derived mycotoxins in ED is largely justified by the 
seasonality of the disease [30;31] and the geographic and temporal clustering of cases [32], which 
likely reflect climatic influences on etiological agent exposure [30;33].  
 
Table 1: Factors which support and refute involvement of C. botulinum in ED.  
Supportive Factors Refutative Factors 
 Reportedly successful historic botulinum 
vaccine trial (1922 and 1923) [2] 
 Disease phenotypic differences between 
ED and neuroparalytic botulism [4] 
 Significantly greater prevalence of 
intestinal C. botulinum bacteria and/or 
toxin in ED cases versus control animals 
[27-29] 
 Greater prevalence of other (non-
botulinum) clostridial species in intestinal 
tract of ED cases versus controls 
(possibly reflecting generalized 
clostridial overgrowth) [34;35] 
 Risk factors supportive of involvement of 
a soil-borne agent [36;37] 
 Neuropathology apparently inconsistent 
with action of C. botulinum neurotoxins 
[38] 
 Inverse association between disease risk 
and systemic concentration of antibodies 
against C. botulinum bacteria and toxin 
[39] 
 SNARE protein expression in EGS 
ganglion and enteric neurons inconsistent 
with action of C. botulinum neurotoxins 
[38] 
 Higher mucosal IgA against BoNT/C and 
D in acute ED cases versus control 
animals [40] 
 Lack of evidence of temporal and 
geographic clustering of ED and 
neuroparalytic botulism cases 
 
Patient History 
Consideration of the history of both the patient and the premises is beneficial in ED diagnosis. 
Appropriate questioning of the owner will allow the clinician to ascertain which of the published 
risk factors apply to the case and consider the diagnostic value of any relevant associations. A 
summary of the various published horse-, premises, management- and climate-level factors 
associated with either an increased or decreased risk of ED occurrence, or recurrence on a 
previously affected premises, is presented in Table 2. It is worth noting that, despite a general 
agreement between studies, occasional inconsistencies exist with regard to some of these reported 
associations. 
 
Table 2: Factors associated with increased (↑) or decreased (↓) risk of ED occurring (occ), or 
recurring on the same premise (rec).  
Level Factor ↑ or ↓ risk 
Horse-level Age (2-7 years) [30;31] ↑ (Occ) 
Low serum antibodies to C. botulinum type C and BoNT/C [39] ↑ (Occ) 
Good body condition [31] ↑ (Occ) 
Contact with a previous ED case [30] ↓ (Occ) 
Premises-level Previous ED occurrence on premises [30;36] ↑ (Occ) 
High soil nitrogen content [36;41] ↑ (Occ) 
Pasture/soil disturbance [36] ↑ (Occ) 
High number of horses [31] ↑ (Occ) 
Presence of younger animals [37] ↑ 
(Occ/Rec) 
Stud farms/livery and riding establishments [37] ↑ (Rec) 
Loam and sandy soils [37] ↑ (Rec) 
Rearing of domestic birds [37] ↑ (Rec) 
High herbage iron, lead, arsenic and chromium [41] Association 
Abundance of Ranunculus spp (buttercups) [41] Association 
High soil titanium [42] ↑ (Occ) 
Low soil zinc and chromium [42] ↑ (Occ) 
Chalk soil [37] ↓ (Rec) 
Management-
level 
Grazing [30;31] ↑ (Occ) 
Recent movement (especially within preceding 2 weeks) [30;31] ↑ (Occ) 
Change in feed type/quantity within preceding 2 weeks [39] ↑ (Occ) 
Ultimate and penultimate use of an ivermectin-based anthelmintic 
[39] 
↑ (Occ) 
Mechanical removal of feces from pasture [37] ↑ (Rec) 
Manual removal of feces from pasture [37] ↓ (Rec) 
Grass cutting [37] ↓ (Rec) 
Co-grazing with ruminants [37] ↓ (Rec) 
Feeding of supplementary hay/haylage [39] ↓ (Occ) 
Climate-level Recent (within 10-14 days) cool, dry weather and irregular 
ground frosts [33] 
↑ (Occ) 
Increased sun hours and frost days [33;43] ↑ (Occ) 
Higher average maximum temperature [43] ↓ (Occ) 
 
As well as carefully considering the applicability of some of the risk factors in each case, a 
careful clinical history should also be obtained. Typically, severe (acute) cases of ED will have a 
sudden onset, with little prior indication of impending disease. In contrast, mild (chronic) cases 
will typically have an insidious onset, where retrospective consideration will often reveal a more 
protracted, yet recent change in demeanor, reduction in feed intake and/or weight loss.  
 
 
Physical Examination 
The clinical phenotype of the case is largely determined by the severity of neuronal loss [44]; 
partly within the ANS, but predominantly within the ENS. Consequently, the clinical 
presentation of a severely affected case will differ quite markedly from that of a mildly affected 
case, despite an identical neuroanatomical distribution of lesions. Similarly, physical examination 
findings and ancillary diagnostic test results derived from ED cases of differing severities can 
often reveal quite disparate results. Consequently, the terms acute, subacute and chronic are 
generally applied to reflect severely, moderately and mildly affected cases, respectively; although 
one should remain aware that these are relatively arbitrary terms applied to a continuum of 
disease severities, with inevitable overlap between each. However, adoption of this terminology 
can be clinically beneficial from a prognostic viewpoint. Since a proportion of chronic cases may 
survive, their differentiation from acute and sub-acute cases, which are invariably fatal, is 
important. Table 3, which summarizes the clinical signs associated with the acute/sub-acute 
(combined) and chronic ED sub-categories, highlights the fact that, although certain clinical 
findings are common to all 3 sub-categories, others are more typical of a specific sub-category. 
The reader is referred to other publications which cover the clinicopathologic correlates 
associated with each individual clinical sign in more detail [3;5;45].  
 
 
 
Table 3: Clinical signs associated with the 3 sub-categories of ED (acute and sub-acute ED 
[combined] and chronic ED).  
 
Clinical Sign Acute/Sub-acute ED Chronic ED 
Dull 
demeanour 
Present – generally more prevalent 
sign than moderate/severe colic  
Present - generally less severe than 
acute/sub-acute ED 
Reduced 
appetite 
Acute - usually profoundly anorexic 
Sub-acute – variable 
Common, but variable severity and 
often progressive in the early stages of 
disease 
Clinical 
dehydration 
Often apparent in acute ED, less so 
in sub-acute ED 
Mild in some cases, dependent on 
degree of dysphagia 
Tachycardia 
Acute: typically 80 - 120 bpm 
Sub-acute: typically 60 – 80 bpm 
Typically 45 – 60 bpm 
Bilateral ptosis Almost invariably present Almost invariably present 
Hypersalivation 
Acute: Often marked intermittent 
drooling evident. No nasal return of 
saliva 
Sub-acute: rarely present 
Not a feature of chronic ED 
Dysphagia 
Often profoundly dysphagic, 
although can be difficult to recognise 
if anorexic 
Varying degrees of dysphagia; valuable 
prognostic indicator 
Rhinitis sicca 
Acute: rarely appreciable 
Sub-acute: may detect slight drying 
and hyperemia of the nasal mucosa 
Variable severity 
Over time, large casts develop within 
nasal cavities resulting in stertor 
Inverse relationship with appetite 
Sweating 
Varies from patchy to generalised Patchy sweating 
May worsen during periods of 
excitement / anxiety 
Abdominal 
pain 
Inconsistently present; if present – 
usually mild to moderate 
Not consistent with degree of 
tachycardia 
Usually absent; if present – usually 
intermittent (e.g. post-prandial) and 
mild 
 
Intestinal 
sounds 
Often complete absence of intestinal 
sounds 
Usually reduced, rarely absent 
Abdominal 
shape 
Occasional abdominal distension due 
to large intestinal tympany 
Rapid development of characteristic 
“tucked up” abdominal silhouette 
(“greyhound-like” appearance) 
Muscle tremors 
Muscle tremors over triceps, flanks 
and quadriceps 
Muscle tremors over triceps, flanks and 
quadriceps 
Rectal 
temperature 
Normal or elevated rectal 
temperature (up to 40oC) 
Normal or mild elevation in rectal 
temperature 
Stance Acute: Normal stance 
Sub-acute: May develop base-
narrow stance over a few days 
Base-narrow (“elephant on a tub”) 
stance 
Other clinical 
signs 
 
 
--------- 
Paraphimosis in entire males (less 
common in geldings) 
Oesophageal choke and aspiration 
pneumonia may develop as secondary 
complication of dysphagia 
 
 
 
Ancillary Diagnostic Tests 
A variety of ancillary diagnostic tests can significantly improve the diagnostic accuracy when 
presented with a suspected case of ED. These can be considered as either (a) reflecting non-
specific hematological, biochemical, bacteriological and/or physiological consequences of the 
disease, (b) reflecting the degree of ANS and/or ENS dysfunction, (c) reflecting other 
neurological deficits not attributable to ANS/ENS involvement and (d) providing 
histopathological evidence of neuronal degeneration. These are summarized in Table 4 a-d. 
 
Table 4: Ancillary diagnostic tests which can be utilized in the diagnostic approach to suspected 
cases of ED.  
 
Diagnostic test objective Diagnostic test Comment 
Identification of non-
specific ED-associated 
hematological, 
biochemical, physiological 
and/or bacteriological 
abnormalities 
Increased hematocrit [46] Reflective of total body water loss (e.g. 
small intestinal sequestration [acute 
ED], neurogenic impairment of 
drinking)  
Elevated serum urea 
concentration [46] 
Reflective of total body water loss  
Elevate serum acute 
phase protein 
concentration [47;48 
Reflective of systemic inflammatory 
response 
Elevated urine specific 
gravity, protein and 
creatinine concentration 
[49] 
Reflective of attempted water retention 
(see above) 
Elevate peritoneal fluid 
specific gravity and 
protein concentration 
[50;51] 
 
Fecal C. perfringens 
detection (ELISA) [34] 
Considered to reflect non-specific 
clostridial overgrowth in dysmotile 
bowel 
Identification of ANS 
and/or ENS dysfunction  
Temporary reversal of 
ptosis following topical 
application of 0.5% 
phenylephrine 
ophthalmic solution to 
the conjunctival sac 
[52;53] 
Confirms smooth muscle paralysis 
(Müller’s superior tarsal muscle) as the 
mechanism underlying the ptosis  
Barium swallow study 
[54] 
Retrograde flow reflecting abnormal / 
uncoordinated esophageal motility 
Esophagoscopy [5] Evidence of retrograde flow of gastric 
fluid – either visualized or reflected by 
the presence of distal esophageal linear 
ulceration  
Nasogastric intubation 
[5] 
Voluminous foul smelling gastric fluid 
reflux, potentially reflective of severe 
gastrointestinal ileus (acute ED) 
Abdominal 
ultrasonography [5] 
Distended small intestinal loops visible, 
potentially reflective of generalized 
gastrointestinal ileus (acute ED) 
Transrectal palpation [5] Distended small intestinal loops 
palpable, potentially reflective of 
generalized gastrointestinal ileus (acute 
ED) 
Firm corrugated colonic and cecal 
contents, potentially reflective of large 
intestinal ileus and desiccation of 
fibrous ingesta 
Identification of non-
ANS/ENS neurological 
dysfunction 
Electromyography [55] Reported findings considered consistent 
with skeletal muscle neuropathy 
Histopathological 
evidence of 
neuropathology at 
appropriate anatomical 
sites 
Histopathology of ileal 
biopsy (standard H&E 
staining) [7] 
Evidence of neuronal loss and 
chromatolysis within myenteric and 
submucous plexuses 
Formalin fixed – 100% sensitive and 
specific [56] 
Cryostat sections – sub-optimal (73%) 
specificity (false positives resulting 
from processing artefacts)[56] 
Histopathology of ileal 
biopsy (synaptophysin 
immunostaining) [57] 
Combined assessment of neuronal 
density and intensity of synaptophysin 
immunostaining – reported 100% 
sensitivity and specificity 
Histopathology of rectal 
biopsy 
(standard H&E staining) 
[58] 
Poor sensitivity (21%) when applied to 
partial thickness biopsies due to low 
neuronal density [59] 
Histopathology of rectal 
biopsy 
(BAPP immunostaining) 
(R. Jago pers. comm.) 
Retrospective application of this 
approach yielded 100% sensitivity and 
specificity 
Requires prospective validation 
Histopathology of 
gustatory papillae [60] 
Retrospective application of this 
approach yielded 100% sensitivity and 
high specificity (98%) 
Requires prospective validation 
 
Ancillary diagnostic tests can also be applied to specifically exclude other differential diagnoses. 
With regard to chronic ED, such tests may focus on the elimination of other diseases which 
present with rapid weight loss. With regard to acute ED cases, which present with small intestinal 
ileus and gastric reflux, the principal aim is to rule out other conditions with a similar 
presentation; namely strangulating and non-strangulating small intestinal obstructive lesions. 
Therefore, when presented with acute ED cases, there is a greater degree of investigative urgency 
to enable identification of other conditions which may require immediate surgical intervention. 
Consequently, exploratory laparotomy may be indicated in some acute ED cases, the findings of 
which will determine the need for further diagnostic approaches.  
 
Given that acute ED carries a hopeless prognosis for survival, the clinician must decide whether 
the absence of a surgically correctable lesion at laparotomy is sufficient grounds for euthanasia 
on the basis of ruling out physical obstructions of the small intestine and failing to provide any 
beneficial surgical intervention. Alternatively, more confirmatory diagnostic evidence may be 
warranted before making this decision. Although histopathological examination of an 
appropriately sized formalin-fixed ileal biopsy is 100% diagnostically sensitive and specific [56], 
this requires a sufficient period of time for tissue fixing, thus necessitating recovery from 
anesthesia pending results of the examination. Unfortunately, histopathological examination of 
cryostat sections is not 100% specific (due to processing artefacts), thus risking an erroneous 
diagnosis and potentially an inappropriate euthanasia [56]. 
 
 
Post-mortem diagnostic confirmation 
Post-mortem diagnostic confirmation is warranted given the potential risk to other grazing horses 
on the premises. Implementing short- and long-term risk avoidance strategies (see later) can be 
expensive and labor intensive and understandably more justifiable when ED is confirmed. Gross 
pathological findings generally reflect the extent of involvement of the ENS. For example, fluid 
distension of the small intestine and stomach and linear ulceration of the distal esophagus are 
typical findings in acute ED, whereas sub-acute cases will have firm corrugated impactions of the 
large colon and cecum, typically with a black coating on the surface of the firm ingesta [3;5]. 
Chronic ED cases are typically emaciated with scant intestinal contents, depending on the 
appetite and degree of dysphagia at the time of death [3;5]. Bilateral rhinitis sicca is commonly 
seen in chronic ED.  
 
A definitive diagnosis is achieved by histopathological examination of autonomic (prevertebral 
and paravertebral) ganglia and intestinal ENS plexuses (see before) [61;62]. Autonomic ganglia 
most routinely collected for histopathological examination include the cranial cervical ganglia, 
the cranial and caudal mesenteric ganglia and the abdominal and thoracic sympathetic chain. 
 
Typical histological features include chromatolysis with loss of Nissl substance, eccentricity or 
pyknosis of the nuclei, neuronal swelling and vacuolation, accumulation of intracytoplasmic 
eosinophilic spheroids and axonal dystrophy [8;61-63]. 
 
Treatment of chronic ED; selection of candidates  
As previously stated, the majority of ED cases have a hopeless prognosis. Overall ED is 
associated with an approximately 80% mortality; comprising of 100% mortality in acute and sub-
acute ED and approximately 50% mortality in chronic ED [6;64]. Therefore, the selection of 
candidates for treatment relies firstly on sub-categorizing the case (see Table 2) and secondly, if 
the signs are consistent with chronic ED, selecting the appropriate cases for which treatment is 
indicated. Acute and sub-acute ED cases are invariably fatal [3]; however, supportive care (not 
covered in this review) in the form of intravenous fluid infusion, analgesic administration and 
regular gastric decompression may be initiated to stabilize the patient until a more definitive 
diagnosis is achieved, at which point euthanasia is indicated.  
 
The criteria used for the selection of appropriate chronic cases are relatively arbitrary; however, 
the following list is a useful guide: 
 Ability to swallow, albeit compromised 
 Some remaining appetite, albeit markedly reduced 
 Absence of continuous moderate to severe abdominal pain (rarely will chronic ED cases 
exhibit severe colic) 
 
Additionally, in light of the prolonged period of convalescence required in many cases [6;64], an 
appropriate level of commitment should be declared by the owner; either time commitment if 
they opt for home nursing or financial commitment if they opt to refer to a clinical facility for 
nursing care.  
 
Non-pharmacologic Treatment Options for chronic ED 
Treatment of chronic ED is predominantly intensive nursing care. Assuming the above selection 
criteria are met, the greatest obstacle to survival is typically profound inappetance [3]. 
Consequently, the main aim of the nursing care is to attain an adequate level of voluntary feed 
intake. This generally involves the provision of a selection of highly palatable feeds (ideally high 
in energy and protein). As individual preferences change regularly, it is often necessary to offer a 
variety of feed components and consistencies [5;65]. Although the addition of succulents (e.g. 
carrots, apples) to the diet may improve voluntary feed intake, these alone are insufficient to meet 
the animal’s energy and protein requirements. Feeding small amounts regularly reduces waste 
and is more likely to result in a greater overall feed intake over a 24h period. At the authors’ 
institute, newly hospitalized chronic cases receive 2 hourly small feeds, reducing to 4 hourly 
feeds after approximately 1 week of hospitalization. Both continuous flow enteral feeding and 
total and partial parenteral nutrition has been used in selected cases, with little evidence of a 
positive influence on case outcome [66]. However, via a reduction in the initial rate of weight 
loss, their use may extend the period of time available for a spontaneous improvement in appetite 
to occur. Additional non-pharmacologic approaches include regular hand grazing and light 
exercise in the form of in-hand walking and/or short periods of turn out to pasture.  
 
Pharmacologic Treatment Options for chronic ED 
Pharmacological treatment options in chronic ED can be sub-categorized as follows:  
Appetite stimulants: unfortunately, attempts to pharmacologically improve the appetite of chronic 
ED cases have been unrewarding, as determined by both anecdotal evidence and placebo 
controlled trials [67]. Evaluated drugs include glucocorticoids, brotizalam, diazepam and 
cyproheptadine. 
Pro-kinetics: Administration of the pro-kinetic drug cisapride has been shown to increase dry 
matter intake and decrease transit time [68]. However, as the principal reason for treatment 
failure is a lack of voluntary feed intake and not intestinal dysmotility, the use of such motility 
enhancing drugs is rarely indicated. Furthermore, by definition, chronic cases have sufficiently 
coordinated intestinal motility to maintain an aboral flow of ingesta. 
Analgesics: The judicious use of non-steroidal anti-inflammatory drugs is often beneficial. The 
analgesic properties of these drugs can be useful to combat low grade, intermittent (often post-
prandial) abdominal pain. Furthermore, as ED cases have evidence of low grade systemic 
inflammation (e.g. elevated acute phase proteins) [47;48], the anti-inflammatory properties of this 
class of drugs is theoretically beneficial. Appropriate NSAID therapeutic options includes 
flunixin meglumine (0.5mg/kg PO or IV BID) or phenylbutazone (2.2mg/kg PO or IV BID). 
Antimicrobials: The dysphagia present in most chronic ED cases may result in varying degrees of 
feed aspiration. In such cases, broad spectrum antimicrobial administration is indicated to 
minimize the development of inhalation pneumonia. Commonly adopted empirical antimicrobial 
treatments include oxytetracycline (10mg/kg IV SID), combined gentamicin (6.6mg/kg IV SID) 
and procaine penicillin (12mg/kg IM BID) and trimethoprim sulphonamide (15-30mg/kg PO 
BID). Occasionally, metronidazole (20mg/kg PO TID) may also be indicated  when anaerobic 
infection is suspected. 
 
Treatment Complications and Prognostic Indicators  
Although it can be difficult to predict the response to treatment/nursing early in the disease 
process, a number of factors can be used as potential prognostic indicators. These are itemized 
below: 
Appetite: Although the voluntary feed intake of cases can fluctuate markedly over a 24h or 48h 
period, persistence of complete anorexia for several (e.g. 5) consecutive days generally is a poor 
prognostic indicator, provided that several feed options have been offered. Persistent anorexia 
and associated weight loss remain the principal reasons for euthanasia in cases receiving nursing 
care. 
Magnitude and rate of weight loss: A recent retrospective study of hospitalized chronic ED cases 
demonstrated the prognostic value of considering the magnitude and rate of weight loss over 
specific periods of treatment. Survival prediction curves have the potential to offer useful 
prospective prognostic information on individual cases [64]. 
Rhinitis sicca: Studies have identified an inverse association between survival and the severity of 
rhinitis sicca [69]. It is hypothesized that severe rhinitis sicca will directly and negatively 
influence appetite, potentially via an effect on olfaction. 
Inhalation pneumonia: Some chronic ED cases with severe dysphagia may develop inhalation 
pneumonia as a consequence of feed aspiration. It is worth noting that coughing appears to be a 
poor indicator of this complication; rather, cases become pyrexic and increasingly dull and 
inappetant. Consequently, recognition of this complication is often dependent on regular 
ultrasonographic examinations of the cranioventral thorax, assessing for the presence of lung 
consolidation and occasionally pleural fluid accumulation. 
Fulminant diarrhea: Severe diarrhea has been recognized in a proportion of chronic ED cases, 
usually those receiving supplementary liquid enteral feeding via a nasogastric tube [66]. This is a 
recognized complication of enteral feeding in horses, thought to partly reflect the low fiber 
content of commercially available liquid feeds [70]. However, this complication has also been 
recorded in cases receiving alfalfa slurries, whereby a bacterial overgrowth in the cecum and 
large colon was suspected. Consequently, when adopted in the treatment of ED cases, enteral 
feeding should be introduced gradually and the liquid feed should contain as high a fiber content 
as feasible. 
 
Long-term complications 
Clinical recovery is generally assumed if cases regain appetite and body weight. Although most 
recovered cases will return to their previous level of performance, some residual problems have 
been reported. These include poor exercise tolerance, persistent low grade dysphagia, recurrent 
esophageal obstruction, occasional mild colic episodes and coat changes (piloerection at the site 
of previous sweating) [6;65;71]. Considering that even clinically recovered cases have evidence 
of extensive neuronal loss in the ENS, it has been hypothesized that clinical recovery may partly 
be associated with compensatory mechanisms which have restored and maintained an adequate 
degree of intestinal motility [72]. Interstitial cells of Cajal have been proposed as compensatory 
cellular candidates.  
 
Summary 
ED is a multi-system neuropathy of equids characterized by damage to autonomic, enteric and 
somatic neurons. It has an extremely high mortality rate and significant welfare, emotional and 
financial consequences. The etiology is unknown. 
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